Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385435 (4-((6R or S)-1-(2- chloro-6- cyclopropylbenzoyl)-6...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385488 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385532 ((1R,6S or 1S, 6R)-4- ((S or R)-1-(2-chloro- 6-(1- ...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385479 ((1R or S)-4-((6R or S)-1- (2-chloro-6-(1- (trifluo...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385488 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385535 ((1R,6S or 1S,6R)-4- ((S or R)-1-(2-chloro- 6-(1- (...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385479 ((1R or S)-4-((6R or S)-1- (2-chloro-6-(1- (trifluo...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385478 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385474 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385482 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385481 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385434 (4-((6R or S)-1-(2- chloro-6- cyclopropylbenzoyl)-6...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385478 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385485 ((R o rS)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385482 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385504 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385530 ((1R,2S or 1S,2R)-4- ((S or R)-1-(2-chloro- 6-(1- (...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385484 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385491 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385483 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385512 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (difluorom...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385512 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (difluorom...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385456 (US10287272, Example 5A) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385476 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385483 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385486 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (difluorom...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385490 (4-((R or S)-1-(2-chloro-6-(1- (trifluoromethyl)cyc...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385484 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385486 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (difluorom...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385477 ((R or S)-4-((R or 5)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385393 (4-((R or S)-6-(azetidine- 1-carbonyl)-1-(2- chloro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385401 (4-((R or S)-6-(3-(1H- pyrazol-1-yl)azetidine- 1-ca...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385441 (4-{(6R or S)-1-[(2- chloro-6- cyclopropylphenyl) c...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385511 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385530 ((1R,2S or 1S,2R)-4- ((S or R)-1-(2-chloro- 6-(1- (...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385536 ((1R,6S or 1S,6R)-4- ((S or R)-1-(2-chloro- 6-(1- (...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385391 (US10287272, Example 1B) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385452 (4-((R or S)-1-(2- chloro-6-cyclopropyl- 3-fluorobe...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385508 (4-((R or S)-1-(2- chloro-6-(1- (trifluoromethyl)cy...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385534 ((1R,2S or 1S,2R)-4- ((S or R)-1-(2-chloro- 6-(1- (...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385415 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385433 (4-((6R or S)-1-(2- chloro-6- cyclopropylbenzoyl)-6...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385454 (4-((R or S)-1-(2- chloro-6-cyclopropyl- 3-fluorobe...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385481 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385507 (4-((R or S)-1-(2- chloro-6-(1- (difluoromethyl)cyc...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385529 (US10287272, Example 17A) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385532 ((1R,6S or 1S, 6R)-4- ((S or R)-1-(2-chloro- 6-(1- ...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385404 (4-((R or S)-6-(3-(4H- 1,2,4-triazol-3- yl)azetidin...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385511 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385392 (US10287272, Example 2A) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385426 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385489 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385400 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385403 (4-((R or S)-6-(3-(4H- 1,2,4-triazol-4- yl)azetidin...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385432 (4-((6R or S)-1-(2- chloro-6- cyclopropylbenzoyl)-6...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385485 ((R o rS)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385509 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385475 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385505 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385509 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385527 (US10287272, Example 15A | US10287272, Example 16A) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385489 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385510 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385431 (4-((R or S)-2-chloro- 6-cyclopropylbenzoyl)- 6-(6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385437 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385430 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385395 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385396 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385519 (US10287272, Example 11A | US10287272, Example 12A) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385471 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385394 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385414 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385412 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385442 (4-{(6R or S)-6-{[6- (tert-butoxycarbonyl)- 2,6-dia...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385411 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385455 (4-((R or S)-1-(2- chloro-6-cyclopropyl- 3-fluorobe...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385444 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385399 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385450 (4-((R or S)-1-(2- chloro-6-cyclopropyl- 3-fluorobe...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385480 ((R or S)-4-((6R or S)-6- (3-(azetidin-1- yl)pyrrol...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385487 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385402 (4-((R or S)-6-(3-(1H- imidazol-1-yl)azetidine- 1-c...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385502 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385487 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385425 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385473 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385451 (4-((R or S)-1-(2- chloro-6-cyclopropyl- 3-fluorobe...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385462 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385445 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385439 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385470 ((1R or S)-4-((6R or S)-1- (2-chloro-6-(1- (trifluo...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385480 ((R or S)-4-((6R or S)-6- (3-(azetidin-1- yl)pyrrol...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385397 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385440 (4-[(6R or S)-1-[(2- chloro-6- cyclopropylphenyl) c...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385461 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385464 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385510 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385453 (4-((6R or S)-1-(2- chloro-6-cyclopropyl- 3-fluorob...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385436 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385427 (4-((6R or S)-1-(2- chloro-6- cyclopropylbenzoyl)-6...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385429 (4-((R or S)-1-chloro- 6-cyclopropylbenzoyl)- 6-((S...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385407 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385459 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385472 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385398 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385405 (4-((R or S)-6-(3- aminoazetidine-1- carbonyl)-1-(2...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385417 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385463 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385446 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385421 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385460 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385406 (4-((R or S)-6-(3- (aminomethyl)-3- methylazetidine...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385410 (4-((R or S)-6-(azetidin-3- yl(methyl)carbamoyl)- 1...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385408 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385420 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385458 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385538 (US10287272, Example 19A) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385424 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385438 (4-((6R or S)-1-(2- chloro-6- cyclopropylbenzoyl)-6...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385409 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 35 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385465 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385467 ((1R or S)-4-((6R or S)-1- (2-chloro-6-(1- (trifluo...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385537 (US10287272, Example 18A) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385457 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 44 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385526 (4-((6R or S)-1-(2- chloro-6-(1- (trifluoromethyl)c...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 45 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385469 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 49 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385522 (US10287272, Example 14A) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385523 (4-((R or S)-1-(2- chloro-6-(1- (trifluoromethyl)cy...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 55 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385468 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 56 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385445 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 61 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385416 (4-((6R or S)-1-(2- chloro-6- cyclopropylbenzoyl)-6...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 61 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385519 (US10287272, Example 11A | US10287272, Example 12A) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385466 ((R or S)-4-((R or S)-1- (2-chloro-6-(1- (trifluoro...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 65 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385428 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 79 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385413 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 88 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385521 (US10287272, Example 13A) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 92 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385422 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 111 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385418 (4-((6R or S)-1-(2- chloro-6- cyclopropylbenzoyl)-6...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 137 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385527 (US10287272, Example 15A | US10287272, Example 16A) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 281 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385423 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 320 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385524 (4-((R or S)-1-(2- chloro-6-(1- (trifluoromethyl)cy...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 357 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385517 (4-((R or S)-1-(2-chloro-6-cyclopropylbenzoyl)-6-(3...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 446 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385419 (4-((6R or S)-1-(2- chloro-6- cyclopropylbenzoyl)-6...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 452 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385518 (4-((R or S)-1-(2-(azetidin-1-yl)-4-methylnicotinoy...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 508 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385443 (4-((6R or S)-1-(2- chloro-6- cyclopropylbenzoyl)-6...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 525 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385446 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 586 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385390 (US10287272, Example 1A) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 769 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385525 (4-((R or S)-1-(2- chloro-6-(1- (trifluoromethyl)cy...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 802 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Nuclear receptor ROR-gamma (Homo sapiens (Human)) | BDBM385444 (4-((R or S)-1-(2-chloro- 6-cyclopropylbenzoyl)- 6-...) | PDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar | UniChem | US Patent | n/a | n/a | 1.04E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Sharp & Dohme Corp. US Patent | Assay Description To identify novel antagonists of RORgammaT, an assay was developed which employs the interaction of RORgammaT with its co-activator peptide SRC1_2. T... | US Patent US10287272 (2019) | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
